Evidence map›Paper›PMID 25470000›Full record

ArticlePloS one2014

Bioactive copper-doped glass scaffolds can stimulate endothelial cells in co-culture in combination with mesenchymal stem cells.

Subha N Rath, Andreas Brandl, Daniel Hiller, Alexander Hoppe, Uwe Gbureck, Raymund E Horch, Aldo R Boccaccini, Ulrich Kneser

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. RSC advances · 2024
    Article
  4. Article
  5. Review
  6. Biomimetic Scaffolds for Tendon Tissue Regeneration.Biomimetics (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Article
  9. Bioprinting Technologies and Bioinks for Vascular Model Establishment.International journal of molecular sciences · 2023
    Review
  10. Regenerative biomaterials · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Multiscale porosity in mesoporous bioglass 3D-printed scaffolds for bone regeneration.Materials science & engineering. C, Materials for biological applications · 2021
    Article
  18. Review
  19. Development and evaluation of copper-containing mesoporous bioactive glasses for bone defects therapy.Microporous and mesoporous materials : the official journal of the International Zeolite Association · 2020
    Article
  20. Bioactive borate glass triggers phenotypic changes in adipose stem cells.Journal of materials science. Materials in medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Subha N RathDepartment of Plastic and Hand Surgery, University of Erlangen-Nürnberg, Erlangen, Germany; Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Yeddumailaram, Telangana, India.
Andreas BrandlDepartment of Plastic and Hand Surgery, University of Erlangen-Nürnberg, Erlangen, Germany.
Daniel HillerDepartment of Plastic and Hand Surgery, University of Erlangen-Nürnberg, Erlangen, Germany.
Alexander HoppeInstitute of Biomaterials, Department of Materials Science and Engineering, University of Erlangen- Nürnberg, Erlangen, Germany.
Uwe GbureckDepartment for Functional Materials in Medicine and Dentistry, Universtiy of Würzburg, Würzburg, Germany.
Raymund E HorchDepartment of Plastic and Hand Surgery, University of Erlangen-Nürnberg, Erlangen, Germany.
Aldo R BoccacciniInstitute of Biomaterials, Department of Materials Science and Engineering, University of Erlangen- Nürnberg, Erlangen, Germany.
Ulrich KneserDepartment of Plastic and Hand Surgery, University of Erlangen-Nürnberg, Erlangen, Germany; Department of Hand, Plastic and Reconstructive Surgery - Burn Center, University of Heidelberg, Ludwigshafen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioactive glass (BG) scaffolds are being investigated for bone tissue engineering applications because of their osteoconductive and angiogenic nature. However, to increase the in vivo performance of the scaffold, including enhancing the angiogenetic growth into the scaffolds, some researchers use different modifications of the scaffold including addition of inorganic ionic components to the basic BG composition. In this study, we investigated the in vitro biocompatibility and bioactivity of Cu2+-doped BG derived scaffolds in either BMSC (bone-marrow derived mesenchymal stem cells)-only culture or co-culture of BMSC and human dermal microvascular endothelial cells (HDMEC). In BMSC-only culture, cells were seeded either directly on the scaffolds (3D or direct culture) or were exposed to ionic dissolution products of the BG scaffolds, kept in permeable cell culture inserts (2D or indirect culture). Though we did not observe any direct osteoinduction of BMSCs by alkaline phosphatase (ALP) assay or by PCR, there was increased vascular endothelial growth factor (VEGF) expression, observed by PCR and ELISA assays. Additionally, the scaffolds showed no toxicity to BMSCs and there were healthy live cells found throughout the scaffold. To analyze further the reasons behind the increased VEGF expression and to exploit the benefits of the finding, we used the indirect method with HDMECs in culture plastic and Cu2+-doped BG scaffolds with or without BMSCs in cell culture inserts. There was clear observation of increased endothelial markers by both FACS analysis and acetylated LDL (acLDL) uptake assay. Only in presence of Cu2+-doped BG scaffolds with BMSCs, a high VEGF secretion was demonstrated by ELISA; and typical tubular structures were observed in culture plastics. We conclude that Cu2+-doped BG scaffolds release Cu2+, which in turn act on BMSCs to secrete VEGF. This result is of significance for the application of BG scaffolds in bone tissue engineering approaches.

Indexed as

Bone SubstitutesCell DifferentiationCoculture TechniquesCopperEndothelial CellsGlassHumansMesenchymal Stem CellsMicrovesselsOsteogenesisTissue EngineeringTissue ScaffoldsVascular Endothelial Growth Factor ABone SubstitutesCopperVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID25470000
PMCPMC4254617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.